Quest Diagnostics, Inc. (DGX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
James E. Davis
Employees:
49,000
500 PLAZA DRIVE, SECAUCUS, NJ 07094
9735202700

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic info services. It also provides risk assessment services for life insurance industry; and healthcare organizations and clinicians robust information technology solutions.

Data derived from most recent annual or quarterly report
Market Cap 14.892 Billion Shares Outstanding111.323 Million Avg 30-day Volume 878.896 Thousand
P/E Ratio19.7629 Dividend Yield1.8753 EPS6.93
Price to Revenue1.632 Debt to Equity0.6451 EBITDA1.634 Billion
Price to Book Value2.5904 Operating Margin12.7044 Enterprise Value19.461 Billion
Current Ratio1.339 EPS Growth-0.545 Quick Ratio1.055
1 Yr BETA 0.5872 52-week High/Low 156.85 / 118.63 Profit Margin8.9451
Operating Cash Flow Growth-32.7952 Altman Z-Score3.4411 Free Cash Flow to Firm 741.943 Million
Earnings Report2023-07-27
View SEC Filings from DGX instead.

View recent insider trading info

Quest Diagnostics, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DGX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-19 by DIAZ LUIS
  • 4: filed on 2023-05-19 by GREGG VICKY B
  • 4: filed on 2023-05-19 by RING TIMOTHY M
  • 4: filed on 2023-05-19 by LASSITER WRIGHT III
  • 4: filed on 2023-05-19 by DOI TRACEY
  • 4: filed on 2023-05-19 by PFEIFFER GARY M
  • 4: filed on 2023-05-19 by WILENSKY GAIL R
  • 3: filed on 2023-05-19 by DIAZ LUIS
  • 4: filed on 2023-05-19 by MORRISON DENISE M
  • 4: filed on 2023-05-19 by MAIN TIMOTHY L

    • Events (8k)

  • 8-K: filed on 2023-05-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-04-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-17:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WILENSKY GAIL R

    • Director
    		 33,881 2023-05-17 1

    PFEIFFER GARY M

    • Director
    		 26,839 2023-05-17 1

    MAIN TIMOTHY L

    • Director
    		 23,612 2023-05-17 1

    RING TIMOTHY M

    • Director
    		 25,744 2023-05-17 9

    MORRISON DENISE M

    • Director
    		 7,955 2023-05-17 1

    GREGG VICKY B

    • Director
    		 18,571 2023-05-17 5

    DOI TRACEY

    • Director
    		 3,621 2023-05-17 1

    DIAZ LUIS

    • Director
    		 0 2023-05-17 2

    LASSITER WRIGHT III

    • Director
    		 6,092 2023-05-17 1

    PLEWMAN PATRICK SVP FOR DIAGNOSTIC SERVICES

    • Officer
    		 12,319 2023-04-24 7

    KUPPUSAMY KARTHIK SVP, CLINICAL SOLUTIONS

    • Officer
    		 13,115 2023-04-24 7

    DELANEY MARK E SVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 3,480 2023-03-24 3

    RUSCKOWSKI STEPHEN H

    • Director
    		 389,597 2023-03-06 3

    PREVOZNIK MICHAEL E SVP & GENERAL COUNSEL

    • Officer
    		 87,220 2023-03-06 3

    DOHERTY CATHERINE T. SVP, REGIONAL BUSINESSES

    • Officer
    		 145,175 2023-03-06 5

    DAVIS J. E. CEO AND PRESIDENT

    • Officer
    • Director
    		 102,634 2023-03-06 4

    DEPPE MICHAEL J SVP, CORP. CONTROLLER & CAO

    • Officer
    		 68,341 2023-03-06 4

    SAMAD SAM EXECUTIVE VICE PRESIDENT & CFO

    • Officer
    		 20,384 2023-02-23 2

    GARDNER MARK A SVP OF MOLECULAR GEN & ONCOL

    • Officer
    		 2,921 2023-02-23 2

    GUINAN MARK EXECUTIVE VICE PRESIDENT & CFO

    • Officer
    		 98,981 2022-03-07 0

    EGLINTON MANNER CARRIE SVP, ADVANCED DIAGNOSTICS

    • Officer
    		 48,391 2022-03-07 0

    TORLEY HELEN

    • Director
    		 6,260 2021-05-25 0

    MENDEZ MANUEL O. SVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 56,678 2021-02-17 0

    STANZIONE DANIEL

    • Director
    		 28,349 2020-11-23 0

    KLUG ROBERT A VP, CORPORATE CONTROLLER

    • Officer
    		 6,261 2019-03-01 0

    CUNNINGHAM EVERETT SVP, COMMERCIAL

    • Officer
    		 39,032 2019-03-01 0

    BRITELL JENNE K

    • Director
    		 14,479 2018-06-04 0

    LEIDEN JEFFREY M

    • Director
    		 6,000 2018-05-29 0

    COHEN JON R SVP & GROUP EXEC. DIAG. SOL.

    • Officer
    		 31,757 2018-03-08 0

    ZIEGLER JOHN B

    • Director
    		 16,557 2017-02-22 0

    BALDWIN JOHN C MD

    • Director
    		 12,949 2015-08-12 0

    BONGIORNO THOMAS F VP AND CORPORATE CONTROLLER

    • Officer
    		 15,002 2015-02-27 0

    HAYDON JOHN B. SVP, OPERATIONS

    • Officer
    		 19,890 2014-02-13 0

    BUEHLER WILLIAM F

    • Director
    		 26,225 2014-02-12 0

    ORDONEZ KATHY SVP, DIAGNOSTIC SOLUTIONS

    • Officer
    		 9,569 2013-03-31 0

    HAGEMANN ROBERT SVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 162,520 2013-03-05 0

    MOHAPATRA SURYA N CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    		 No longer subject to file 2012-04-30 0

    MILLER JOAN ELIZABETH SVP-ONCOLOGY & NEUROLOGY SRVCS

    • Officer
    		 90,279 2012-02-29 0

    SIMMONS WAYNE R. VICE PRESIDENT, OPERATIONS

    • Officer
    		 47,752 2011-06-16 0

    GLAXOSMITHKLINE PLC

    • Director
    • 10% Owner
    		 No longer subject to file 2011-01-31 0

    HAGGERTY ROSANNE

    • Director
    		 9,334 2010-05-06 0

    GRANT WILLIAM R

    • Director
    		 3,622 2007-04-01 0

    GRANT THOMAS W II SR VP, INS. & EMPLOYER SERV.

    • Officer
    		 4,771 2006-12-31 0

    ZEWE DAVID M SVP, DIAGNOSTIC TESTING OPS

    • Officer
    		 90,041 2006-10-30 0

    FLAHERTY JAMES F III

    • Director
    		 3,667 2006-05-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MAIN TIMOTHY L - Director

    		2023-05-19 18:13:36 -0400 2023-05-17 A 1,369 a 23,612 direct -0.4027 0.0 1 -0.4027 2

    MORRISON DENISE M - Director

    		2023-05-19 18:15:04 -0400 2023-05-17 A 1,369 a 7,955 direct -0.4027 0.0 1 -0.4027 2

    WILENSKY GAIL R - Director

    		2023-05-19 18:17:44 -0400 2023-05-17 A 1,369 a 20,506 direct -0.4027 0.0 1 -0.4027 2

    PFEIFFER GARY M - Director

    		2023-05-19 18:18:52 -0400 2023-05-17 A 1,369 a 26,839 direct -0.4027 0.0 1 -0.4027 2

    DOI TRACEY - Director

    		2023-05-19 18:20:00 -0400 2023-05-17 A 1,369 a 3,621 direct -0.4027 0.0 1 -0.4027 2

    LASSITER WRIGHT III - Director

    		2023-05-19 18:21:01 -0400 2023-05-17 A 1,369 a 6,092 direct -0.4027 0.0 1 -0.4027 2

    RING TIMOTHY M - Director

    		2023-05-19 18:22:46 -0400 2023-05-17 A 1,369 a 25,744 direct -0.4027 0.0 1 -0.4027 2

    GREGG VICKY B - Director

    		2023-05-19 18:24:10 -0400 2023-05-17 A 1,369 a 18,571 direct -0.4027 0.0 1 -0.4027 2

    DIAZ LUIS - Director

    		2023-05-19 18:25:18 -0400 2023-05-17 A 1,369 a 1,369 direct -0.4027 0.0 1 -0.4027 2

    KUPPUSAMY KARTHIK - Officer SVP, CLINICAL SOLUTIONS

    		2023-04-25 17:47:58 -0400 2023-04-24 L 25 $143.08 a 11,295 direct -3.9703 -6.994 0.0 1 -6.994 6

    GREGG VICKY B - Director

    		2023-04-25 17:45:56 -0400 2023-04-24 L 72 $143.08 a 17,202 direct -3.9703 -6.994 0.0 1 -6.994 6

    PLEWMAN PATRICK - Officer SVP FOR DIAGNOSTIC SERVICES

    		2023-04-25 17:50:15 -0400 2023-04-24 L 44 $143.08 a 12,319 direct -3.9703 -6.994 0.0 1 -6.994 6

    RING TIMOTHY M - Director

    		2023-04-04 16:35:09 -0400 2023-04-03 A 291 a 13,431 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    QUEST DIAGNOSTICS INC DGX 2023-05-29 22:15:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 21:45:05 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 21:15:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 20:45:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 20:15:05 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 19:45:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 19:15:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 18:45:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 18:15:03 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 17:45:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 17:15:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 16:45:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 16:15:03 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 15:45:03 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 15:15:03 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 14:45:05 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 14:15:04 UTC 4.82 0.25 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 13:45:05 UTC 4.6619 0.4081 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 13:15:03 UTC 4.6619 0.4081 3600000
    QUEST DIAGNOSTICS INC DGX 2023-05-29 12:45:03 UTC 4.6619 0.4081 3600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund DGX -7217.0 shares, $-885453.73 2022-09-30 N-PORT
    JPMorgan Trust I- JPMorgan Research Market Neutral Fund DGX -1408.0 shares, $-209059.84 2023-01-31 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund DGX -2024.0 shares, $-300523.52 2023-01-31 N-PORT
    Nuveen Investment Trust II- Nuveen Equity Long/Short Fund DGX -2100.0 shares, $-290556.0 2023-02-28 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Carol Devine Miller republican House Filing 2022-12-05 2022-11-14 P $1,001-$15,000

    Elevate your investments